Adar1 Capital Management, LLC Axsome Therapeutics, Inc. Transaction History
Adar1 Capital Management, LLC
- $500 Billion
- Q4 2024
A detailed history of Adar1 Capital Management, LLC transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Adar1 Capital Management, LLC holds 19,661 shares of AXSM stock, worth $2.4 Million. This represents 0.33% of its overall portfolio holdings.
Number of Shares
19,661
Previous 600
3176.83%
Holding current value
$2.4 Million
Previous $53.9 Million
2985.04%
% of portfolio
0.33%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding AXSM
# of Institutions
351Shares Held
36.3MCall Options Held
1.77MPut Options Held
1.16M-
Rtw Investments, LP New York, NY4.05MShares$495 Million5.59% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.9MShares$477 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$403 Million0.01% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA1.47MShares$179 Million24.98% of portfolio
-
Bvf Inc San Francisco, CA1.39MShares$170 Million4.4% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $5.24B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...